The field requires urgent Phase I/II human trials before any clinical recommendations can be made
BPC-157 + TB-500 Blend is a combination of two synthetic peptides widely studied in preclinical research for their role in cellular response processes, tissue remodeling, angiogenesis, and regulation of the extracellular matrix
The original 2015 Cell Metabolism study demonstrated that intraperitoneal MOTS-c injections (5 mg/kg) in mice fed a high-fat diet prevented obesity and insulin resistance, with effects on fat mass, fasting glucose, and insulin sensitivity that rivaled pharmaceutical intervention [1]
Document weekly dose, injection site, and any adverse effects to maintain consistency
Stick within your providers recommended dosage and frequency schedule for maximum benefits without going overboard
The American College of Obstetricians and Gynecologists (ACOG) and the American Diabetes Association (ADA) continue to recommend human insulin as the standard of care in pregnant women with diabetes mellitus and gestational diabetes mellitus (GDM) requiring medical therapy
